Global Facial Injectables Market 2016-2020
Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
Technavio’s analysts forecast the global facial injectables market to grow at a CAGR of 9.75% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global facial injectables market for 2016-2020. To calculate the market size, the report considers the revenue generated through the sales of injectables.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Facial Injectables Market 2016-2020
Technavio recognizes the following companies as the key players in the global facial injectables market: Allergan, Bloomage BioTechnology, Galderma, and Merz Aesthetics.
Other Prominent Vendors in the market are: AQTIS Medical, ColBar LifeScience, Hangzhou Techderm Biological Products, Laboratory Obvieline, Medytox, Polymekon, Qufu Guanglong Biochem, Revitacare, Suneva Medical, SciVision Biotech, Speciality European Pharma, Syneron, and Visionmed.
Commenting on the report, an analyst from Technavio’s team said: “The combination of various cosmetic surgeries has become a new trend in the market. Surgeons started adopting a combination of surgical and non-surgical procedures to provide more comprehensive results. Many surgeons have started using a combination of treatments such as Sculptra aesthetic injectables, dermal fillers, and cheek lift surgery to achieve the desired outcome. This combination treatment may also help in increasing the efficacy for a long-period. Also, the combination of dermal fillers, energy-based devices, neurotoxins, and less invasive surgeries customized to the specific requirements of each patient yield better result compared to a single treatment option.”
According to the report, with the increasing beauty consciousness among people more and more people are becoming aware of anti-aging measures. This acts as one of the major drivers for the global facial injectables market. A number of women and men are undergoing medical aesthetic procedures for a youthful appearance. The ASAPS estimated that medical facilities in the US performed more than 11 million cosmetic surgical and non-surgical procedures in 2013. In 2014, the organization also estimated that more than 10.3 million women and one million men underwent cosmetic procedures, accounting for 90.6% and 9.4% of the overall medical cosmetic procedures, respectively.
Further, the report states that all medical procedures are associated with a certain degree of risk. The various side effects associated with the use of Botox and dermal facial fillers is a major challenge hindering the growth of the market. Botox may cause serious life-threatening side effects. For instance, there can be problems related to swallowing, breathing, or speaking, due to the weakening of associated muscles. The spread of toxin effects is another risk associated with facial injectables. The effect of botulinum toxin will also affect areas away from the injection site and cause serious symptoms including loss of strength and muscle weakness, blurred vision and drooping eyelids, double vision, hoarseness or loss of voice, difficulty in speaking, trouble breathing, and trouble swallowing.
Allergan, Bloomage BioTechnology, Galderma, Merz Aesthetics, AQTIS Medical, ColBar LifeScience, Hangzhou Techderm Biological Products, Laboratory Obvieline, Medytox, Polymekon, Qufu Guanglong Biochem, Revitacare, Suneva Medical, SciVision Biotech, Speciality European Pharma, Syneron, Visionmed.